A 2024 trial showed statin drugs markedly lower GLP-1 hormone levels, but most physicians missed it. A letter and video about the findings sparked media coverage and got the study onto Cell Metabolism's most-read list, showing how grassroots attention can shift what gets noticed in academic medicine.
Wow, you guys are incredible. You can change science and medicine, and here's proof. I recently wrote a letter and made a video on what I called the most underrated study of 2024. It was a human-controlled trial showing that statin drugs significantly reduced GLP-1 levels. I was stunned that so few doctors and cardiologists seemed to be aware of this research, and I felt these were really relevant data that should be disclosed to patients to facilitate just responsible informed consent. Turned out that content took off. It was picked up by major media outlets and inspired other creators. And as of the morning that I record this, the paper, which had largely gone unnoticed under the rug for over a year and a half, is now on Cell Metabolism's most read list. That's all thanks to you. Your passion can generate a groundswell, a bottom-up influence to direct the spotlight of academic medicine. You are powerful. Thank you.
